Table 1 Characteristics of the patients enrolled after the stabilization diet period by treatment group

Age (years)

53.6

12.3

49.9

14.5

53.0

11.2

Total Energy Intake (kcal)

2284

139

2310

137

2271

148

Fat dietary intake (% on total energy)

26.9

2.8

27.2

2.9

27.5

3.0

Saturated fat intake (Fat dietary intake (% on total energy)

11.1

1.4

10.2

1.3

10.9

1.3

Protein intake (% on total energy)

18.1

2.1

17.9

2.2

17.2

2.3

Carbohydrate intake (% on total energy)

51.4

3.2

50.6

3.1

51.2

4.0

Cholesterol intake (mg)

196.4

9.3

190.9

9.1

198.9

10.1

Waist circumference (cm)

88.9

10.4

85.1

8.9

90.2

12.8

Body Mass Index (Kg/m2)

25.0

2.6

25.2

2.9

25.6

3.4

Systolic blood pressure (mmHg)

130.7

17.2

122.5

15.8

124.4

17.1

Diastolic blood pressure (mmHg)

79.4

12.3

76.7

14.0

80.0

10.6

Pulse pressure (mmHg)

51.3

10.9

45.7

9.8

44.4

14.3

Total Cholesterol (mg/dl)

220.9

26.7

235.8

23.0

237.9

27.7

Triglycerides (mg/dl)

136.4

75.7

121.8

53.5

109.4

44.3

HDL-Cholesterol (mg/dl)

46.7

13.1

53.1

11.4

48.9

12.8

LDL-Cholesterol (mg/dl)

146.8

27.3

158.3

21.1

167.1

25.1

ApolipoproteinA1 (mg/dl)

140.9

20.6

158.1

22.4

148.6

29.4

ApolipoproteinB100 (mg/dl)

92.4

17.9

98.4

15.9

101.4

19.1

Glucose (mg/dl)

91.6

8.6

88.6

10.9

90.3

13.2

Uricemia (mg/dl)

5.4

1.1

4.8

1.3

5.1

1.14

Creatinine (mg/dl)

0.98

0.14

0.92

0.13

0.98

0.16

eGFR (CKD-EPI equation) (ml/min/1.73 m2)

77.9

15.0

81.9

16.6

79.1

11.9

AST (U/l)

21.3

4.6

20.0

5.4

19.5

4.9

ALT (U/l)

25.2

9.7

21.6

8.6

22.0

9.6

Gamma-Glutamyl Transferase (U/l)

29.2

27.7

22.8

16.9

18.3

7.8

Creatine Posphokinase (U/l)

125.1

86.8

136.4

66.8

118.5

73.8